Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2026-02-21 @ 8:28 PM
Study NCT ID:
NCT02418104
Status:
COMPLETED
Last Update Posted:
2016-01-07
First Post:
2015-04-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessing the Immunogenicity of 2 Subcutaneous Doses of CHS-1701 (Coherus Pegfilgrastim) With 2 Subcutaneous Doses Neulasta®
Sponsor:
Coherus Oncology, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CHS-1701-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None